نتائج البحث - "Andrej, Janež"

المصدر: Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Cardiovascular Diabetology
Cardiovascular diabetology, London : BioMed Central, 2019, vol. 18, no. 1, art. no. 115, p. 2461-2498

مصطلحات موضوعية: Research design, lcsh:Diseases of the circulatory (Cardiovascular) system, CVOTs, EMPA-REG OUTCOME, EMPRISE, heart failure, real-world evidence, type 2 diabetes, Endocrinology, Diabetes and Metabolism, Diabetes Mellitus, Type 2 / diagnosis, Disease, 030204 cardiovascular system & hematology, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, 0302 clinical medicine, Glucosides, Risk Factors, Practice Patterns, Physicians', Diabetes Mellitus, Type 2 / mortality, Real-world evidence, Clinical Trials as Topic, Evidence-Based Medicine, Type 2 diabetes, 3. Good health, Hospitalization, Cardiovascular Diseases / diagnosis, Treatment Outcome, Cardiovascular Diseases, Research Design, Practice Guidelines as Topic, Cardiology and Cardiovascular Medicine, Risk assessment, medicine.medical_specialty, Clinical Decision-Making, 030209 endocrinology & metabolism, Context (language use), Heart failure, Risk Assessment, Glucosides / therapeutic use, 03 medical and health sciences, Sodium-Glucose Transporter 2 Inhibitors / adverse effects, Internal medicine, medicine, Empagliflozin, Humans, Benzhydryl Compounds, Intensive care medicine, Sodium-Glucose Transporter 2 Inhibitors, business.industry, Cardiovascular Diseases / therapy, Perspective (graphical), Evidence-based medicine, Clinical Trials as Topic / methods, Protective Factors, Interim analysis, Glucosides / adverse effects, Benzhydryl Compounds / adverse effects, Cardiovascular Diseases / mortality, Diabetes Mellitus, Type 2, Benzhydryl Compounds / therapeutic use, lcsh:RC666-701, Commentary, business, Diabetes Mellitus, Type 2 / drug therapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abaca1091153e7f4b6d344fa0c211417Test
http://link.springer.com/article/10.1186/s12933-019-0920-3Test

7

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

المؤلفون: Jan Škrha, Ilze Konrāde, Guntram Schernthaner, Fahim Ebrahimi, Alexander Ametov, Peter Fasching, Naim Shehadeh, Nebojsa Lalic, Péter Kempler, Žydrūnė Visockienė, Anna V. Bazarova, Emil Martinka, Andrej Janež, Tsvetalina Tankova, Cristian Serafinceanu, Dario Rahelić, Boris Mankovsky

المصدر: Cardiovascular diabetology [electronic resource], BioMed Central, 2020, vol. 19, iss. 1, art. no. 185, p. 1-17
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-17 (2020)
Cardiovascular Diabetology

مصطلحات موضوعية: Blood Glucose, lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Clinical Decision-Making, Glycemic Control, Type 2 diabetes, Disease, Global Health, Incretins, Risk Assessment, Glucose lowering drugs, Glucagon-Like Peptide-1 Receptor, cardiorenal protection, clinical inertia, glucose lowering drugs, type 2 diabetes, Risk Factors, Internal medicine, Diabetes mellitus, medicine, Humans, Practice Patterns, Physicians', Medical prescription, Sodium-Glucose Transporter 2 Inhibitors, Angiology, Glucose lowering, Evidence-Based Medicine, High risk patients, business.industry, Cardiorenal protection, Protective Factors, medicine.disease, Clinical inertia, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, lcsh:RC666-701, Heart failure, Practice Guidelines as Topic, Commentary, Kidney Diseases, Cardiology and Cardiovascular Medicine, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0730bfeff4fb75c30f0f6ccc4b51c36Test
https://doi.org/10.1186/s12933-020-01154-wTest

8

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus

المؤلفون: Mišo Šabovič, Andrej Juretič, Mojca Lunder, Andrej Janež, Miodrag Janić, Miha Japelj

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-8 (2018)

مصطلحات موضوعية: Blood Glucose, Male, lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Slovenia, Empagliflozin, Pilot Projects, 030204 cardiovascular system & hematology, 0302 clinical medicine, Glucosides, Prospective Studies, 030212 general & internal medicine, Brachial artery, Pulse wave velocity, Original Investigation, Empagliflozin/metformin, Arteries, Middle Aged, Arterial stiffness, Metformin, Vasodilation, Treatment Outcome, Cardiology, Drug Therapy, Combination, Cardiology and Cardiovascular Medicine, medicine.drug, Adult, medicine.medical_specialty, Placebo, 03 medical and health sciences, Vascular Stiffness, Double-Blind Method, Vascular protection, Diabetes mellitus, Internal medicine, medicine.artery, medicine, Humans, Hypoglycemic Agents, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, Type 1 diabetes, business.industry, nutritional and metabolic diseases, Endothelial function, Recovery of Function, medicine.disease, Diabetes Mellitus, Type 1, lcsh:RC666-701, Endothelium, Vascular, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d95073c1714dbaba90467de93573f6Test
https://doi.org/10.1186/s12933-018-0797-6Test

9

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

المؤلفون: Kristine Ducena, Lea Duvnjak, Tsvetalina Tankova, Leszek Czupryniak, Roger Lehmann, Guntram Schernthaner, Marina V. Shestakova, Péter Kempler, Martin Prázný, Andrej Janež, Avraham Karasik, Peter Fasching, Emil Martinka

المساهمون: University of Zurich, Schernthaner, Guntram

المصدر: Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-12 (2017)
Cardiovascular Diabetology

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, Keywords: Anti-glycaemic drugs, Cardiovascular disease, Renal disease, Type 2 diabetes, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, 10265 Clinic for Endocrinology and Diabetology, Delphi method, 610 Medicine & health, 030209 endocrinology & metabolism, Review, Disease, 030204 cardiovascular system & hematology, Anti-glycaemic drugs, 2705 Cardiology and Cardiovascular Medicine, Translational Research, Biomedical, 03 medical and health sciences, 0302 clinical medicine, Multidisciplinary approach, Diabetes mellitus, Diabetes Mellitus, medicine, Humans, Hypoglycemic Agents, Europe, Eastern, Intensive care medicine, Expert Testimony, Clinical Trials as Topic, business.industry, medicine.disease, Expert group, Europe, Eastern european, 2712 Endocrinology, Diabetes and Metabolism, Treatment Outcome, 2724 Internal Medicine, Cardiovascular Diseases, lcsh:RC666-701, Practice Guidelines as Topic, Cardiology and Cardiovascular Medicine, business, Kidney disease

وصف الملف: s12933-017-0622-7.pdf - application/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f6726801d5726413871487382e0c62Test
https://doi.org/10.1186/s12933-017-0622-7Test

تنقيح النتائج